Annual profit/loss of Sobi 2009-2019

The Swedish biopharmaceutical company Sobi made annual losses in many years of the observed period from 2009 to 2019. However, the latest five years the company made profits which increased significantly, and in 2019 Sobi made annual profits of around 3.3 billion Swedish kronor.

Annual profit/loss of Sobi from 2009 to 2019

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

only $59 / month *
in the first 12 months
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in

Release date

April 2020



Survey time period

2009 to 2019

Supplementary notes

Sobi (Swedish Orphan Biovitrum) is a Swedish biopharmaceutical company founded in 2001. The company produces biopharmaceuticals aimed to treat rare diseases.

Some figures are taken from previous publications.

Some numbers has been rounded from the original source.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 / Month *
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract; Prices do not include sales tax.

Statistics on "Pharmaceutical industry in Sweden "

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.